Go Pro

PACS Group, Inc. (NYSE:PACS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

PACS Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst sentiment is moderately bullish: Seven brokerages give PACS Group a consensus “Moderate Buy” rating, with five buys and two holds. The average 12-month price target is $50.60, above the reported share price of $46.48.
  • PACS exceeded quarterly expectations, reporting adjusted EPS of $0.50 versus the $0.42 consensus estimate and revenue of $1.42 billion against expectations of $1.36 billion. Analysts anticipate $2.23 in EPS for the current fiscal year.
  • Insiders have been selling shares: Company insiders sold 796,524 shares worth approximately $31.6 million over the past 90 days, although insiders still own 70.1% of the stock.
  • MarketBeat previews the top five stocks to own by August 1st.

Shares of PACS Group, Inc. (NYSE:PACS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $50.60.

Several research analysts have commented on PACS shares. Weiss Ratings raised shares of PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a report on Wednesday, July 8th. Zacks Research downgraded PACS Group from a "strong-buy" rating to a "hold" rating in a research report on Thursday, May 14th. Truist Financial increased their price target on PACS Group from $50.00 to $52.00 and gave the company a "buy" rating in a research note on Monday, May 18th. Wall Street Zen upgraded PACS Group from a "buy" rating to a "strong-buy" rating in a report on Monday, June 15th. Finally, Oppenheimer lifted their price objective on PACS Group from $42.00 to $48.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 13th.

Get Our Latest Research Report on PACS

PACS Group Trading Down 1.0%

PACS stock opened at $46.48 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.99 and a quick ratio of 0.99. PACS Group has a 1-year low of $7.50 and a 1-year high of $48.00. The business has a 50 day simple moving average of $40.59 and a two-hundred day simple moving average of $37.54. The company has a market capitalization of $7.36 billion, a price-to-earnings ratio of 29.80, a PEG ratio of 1.40 and a beta of -0.08.

PACS Group (NYSE:PACS - Get Free Report) last released its earnings results on Monday, May 11th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.36 billion. Research analysts anticipate that PACS Group will post 2.23 EPS for the current fiscal year.

Insider Activity at PACS Group

In related news, insider Mark Hancock sold 153,254 shares of the company's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $36.34, for a total transaction of $5,569,250.36. Following the sale, the insider owned 54,449,343 shares of the company's stock, valued at $1,978,689,124.62. This represents a 0.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Renee Lewis sold 15,000 shares of the stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $40.01, for a total transaction of $600,150.00. Following the transaction, the chief accounting officer owned 370,338 shares of the company's stock, valued at $14,817,223.38. This trade represents a 3.89% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 796,524 shares of company stock valued at $31,611,396. 70.10% of the stock is owned by corporate insiders.

Institutional Trading of PACS Group

Several hedge funds have recently made changes to their positions in PACS. Handelsbanken Fonder AB bought a new position in shares of PACS Group in the 2nd quarter valued at about $567,000. Financial Management Professionals Inc. raised its position in PACS Group by 54.9% during the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company's stock valued at $28,000 after purchasing an additional 235 shares during the period. Empowered Funds LLC bought a new stake in shares of PACS Group in the 1st quarter valued at approximately $278,000. Western Wealth Management LLC bought a new stake in shares of PACS Group in the 1st quarter valued at approximately $48,000. Finally, Smith Group Asset Management LLC purchased a new position in shares of PACS Group in the 1st quarter worth approximately $771,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

See Also

Analyst Recommendations for PACS Group (NYSE:PACS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in PACS Group Right Now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines